Associated Papers
Effect of donor GSTM3 rs7483 genetic variant on tacrolimus elimination in the early period after liver transplantation.
Zhang T et al.
Peerj, 2024
39465171 (PubMed )
Supplement: peerj-12-18360-s002.7z › drug-metabolizing_enzymes_and_transporter__DMET__microarray › markerlist.xlsx › markerlist.TXT
Inborn Errors of Nucleoside Transporter (NT)-Encoding Genes (SLC28 and SLC29).
Pastor-Anglada M et al.
International Journal of Molecular Sciences, 2022
Functional disruption of pyrimidine nucleoside transporter CNT1 results in a novel inborn error of metabolism with high excretion of uridine and cytidine.
Wevers RA et al.
Journal of Inherited Metabolic Disease, 2019
Characterization of Disease-Associated Mutations in Human Transmembrane Proteins.
Molnár J et al.
Plos One, 2016
26986070 (PubMed )
Supplement: pone.0151760.s001.xlsx › polymorphism
Functional analysis of the human concentrative nucleoside transporter-1 variant hCNT1S546P provides insight into the sodium-binding pocket.
Cano-Soldado P et al.
American Journal of Physiology. Cell Physiology, 2012
Pharmacogenetics and pharmacoepigenetics of gemcitabine.
Candelaria M et al.
Medical Oncology (northwood, London, England), 2010
Pharmacogenetics of cancer chemotherapy.
Abraham J et al.
Biochimica Et Biophysica Acta, 2006
Pharmacogenetics for individualized cancer chemotherapy.
Efferth T et al.
Pharmacology & Therapeutics, 2005
Functional and genetic diversity in the concentrative nucleoside transporter, CNT1, in human populations.
Gray JH et al.
Molecular Pharmacology, 2004
Select a paper to view details